GSEA conducted on all genes (Figure 2C) demonstrated that patients of S-I tended to exhibit more osteoclastic bone resorption (e.g., ACP5, SIGLEC15, CTSK), which was consistent with the clinical manifestations of osteosarcoma at the early stage (39). This evidence concerns the gene SIGLEC15 and osteosarcoma.